Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,400.96
(
-0.16%
)
US TECH 100
28,196.00
(
-1.18%
)
Dow Jones
49,760.56
(
0.11%
)
Brent Oil
104.37
(
-1.31%
)
Bitcoin
81,173.57
(
0.85%
)
News Focus
News Focus
Post# of 518324
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

McMagyar

Send PM Follow Ignore
Followers 44
Posts 10698
Boards Moderated 0
Alias Born 01/13/2016

McMagyar

Re: riverterracekrew post# 81953

Sunday, 12/04/2016 1:34:18 PM

Sunday, December 04, 2016 1:34:18 PM

Post# of 518324
Not our last chance on Mono at 41 Weeks?
How about Parkinson's?
How about all Depressive \ Anxiety indications?
How about our 4 other drugs in development that all show promise?
We have a platform to develop new drugs as good as or better than the ones we already have!
The Combo Patent had some value as to length of non competitive marketing Anavex might enjoy,,but the computer models showing greater effect were just wrong.
Whatever we have lost w Combo we gain 100 fold by replacing Aricept..
It's why we have buyers and sellers.
Sell. Thank You very much
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News